Genetic Technologies Ltd. (GENE)

[DutchBlood_7]

Genomic test kits for personalized/preventative health care in some of the most prevalent diseases in the world.

Company has created genetic risk assessment tests for: breast cancer, colorectal cancer, COVID, cardiovascular diseases, Lynch Syndrome, Depression, melanoma and prostate cancer.

Company tests cover hereditary and non-hereditary components, making it unique on the market.

Company has a 2 year cash runway.

Company has research collaborations with some of the most prestigious institutions in the world including: Cambridge University, Harvard Nurses Health, Ohio State University, Translational Genomics Research Institute and Memorial Sloan Kettering.

Company is pursuing direct to consumer model and has begun selling via online health care portals in the US.

GENOMIC sequencing is the new hot area, largely sparked by Cathie Wood of Ark Investments stating this area is where she will find her NEXT TESLA.

PT $20 near term.